Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
InMed Pharmaceuticals Inc. (INM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/18/2022 |
4/A
| Johnson Shane Aaron (Sr VP & General Manager) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
| 11/18/2022 |
4/A
| MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
| 11/18/2022 |
4/A
| HSU ERIC C (Sr. VP, Pre-Clinical Res/Dev) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Disposed/sold 4,200 options to buy
@ $2.78, valued at
$11.7k
|
|
| 11/18/2022 |
4/A
| ADAMS ERIC A (President & CEO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $2.78, valued at
$41.7k
|
|
| 11/18/2022 |
4/A
| WOUDENBERG MICHAEL (COO) has filed a Form 4 on InMed Pharmaceuticals Inc.|
Txns:
| Disposed/sold 7,500 options to buy
@ $2.78, valued at
$20.9k
|
|
|
|